The lack of a strong set of AI-specific regulation in the U.S. allows innovation to happen quickly, but that also requires companies to be transparent and for the industry to take responsibility for its own actions, says Mika Newton, CEO of xCures. Global By HIMSS TV | March 31, 2025 | 11:21 AM Tags: clinical AI, AI regulation